A new era of choice

NITYR is therapeutically equivalent1 to Orfadin*


  • NITYR (nitisinone) tablets are therapeutically equivalent to Orfadin (nitisinone) capsules
  • Offers additional benefits and may be more convenient
  • Comes with a $0 co-pay for eligible commercially insured patients2
  • You can experience NITYR today with the Three-Week Free Trial3
Find out more about NITYR About the Free Trial

My Story with NITYR

Five-year-old Ethan has hereditary tyrosinemia type 1 (HT-1). Like any family that has a child with this ultra rare condition, Carrie and Mike have found Ethan’s diet and medication regime very demanding. Find out what happened when they discovered NITYR.

Read Ethan's Story

My Diet and What I Can Eat

Living with HT-1 is not only a matter of treatment, but it involves other daily challenges such as diet management and its related expenses. For this reason, we have partnered with Cambrooke Therapeutics™, a global leader in therapeutic medical nutrition, to support our patients in the purchasing of protein formulas and low protein foods.

Dietary Advice Food Program

NITYR (nitisinone) tablets - What I Like about NITYR

Please contact the NITYR Patient Support Program for more information:


1Data on file NIT/02/17  2$0 co-pay for eligible commercially insured patients (up to $15,000 per year per patient)  3Free trial offer: Subject to terms and conditions and eligibility criteria. Patients can try NITYR for three weeks for free as long as their doctor prescribes it. Subject to terms and conditions, eligibility criteria, and to other federal and state law.

*Orfadin is a registered trademark licensed by Sobi, Inc. or its affiliates.